Drug information for BENOXINATE HYDROCHLORIDE

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
SOLUTION/DROPS; OPHTHALMIC 0.4% Discontinued   BENOXINATE HYDROCHLORIDE benoxinate SOLA BARNES HIND 84149

Drug Adverse Effects information for BENOXINATE HYDROCHLORIDE

Role code Indications Reaction # Reports
C AGE-RELATED MACULAR DEGENERATION ATOPY 2
C AGE-RELATED MACULAR DEGENERATION ECZEMA EYELIDS 1
C AGE-RELATED MACULAR DEGENERATION EYE IRRITATION 2
C AGE-RELATED MACULAR DEGENERATION EYELID OEDEMA 2
C AGE-RELATED MACULAR DEGENERATION RETINAL DETACHMENT 2
C AGE-RELATED MACULAR DEGENERATION ULCERATIVE KERATITIS 2
C LOCAL ANAESTHESIA AGITATION 1
C LOCAL ANAESTHESIA BRADYCARDIA 1
C LOCAL ANAESTHESIA CYANOSIS 1
C LOCAL ANAESTHESIA DYSPNOEA 1
C LOCAL ANAESTHESIA HYPERSENSITIVITY 1
C LOCAL ANAESTHESIA OXYGEN SATURATION DECREASED 1
C PRODUCT USED FOR UNKNOWN INDICATION AGITATION 1
C PRODUCT USED FOR UNKNOWN INDICATION BRADYCARDIA 1
C PRODUCT USED FOR UNKNOWN INDICATION CYANOSIS 1
C PRODUCT USED FOR UNKNOWN INDICATION DYSPNOEA 1
C PRODUCT USED FOR UNKNOWN INDICATION HYPERSENSITIVITY 1
C PRODUCT USED FOR UNKNOWN INDICATION OXYGEN SATURATION DECREASED 1
C PROPHYLAXIS AGITATION 2
C PROPHYLAXIS BRADYCARDIA 2
C PROPHYLAXIS CYANOSIS 2
C PROPHYLAXIS DYSPNOEA 2
C PROPHYLAXIS HYPERSENSITIVITY 2
C PROPHYLAXIS OXYGEN SATURATION DECREASED 2
C RETINAL VEIN OCCLUSION ENDOPHTHALMITIS 2
Ads by Google